BACKGROUND: Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) is associated with cognitive impairment which affects psychomotor speed. Psychomotor slowing is a predictor of dementia and death in people living with HIV and AIDS. The purpose of this study was to assess the relationship between HIV disease stage and psychomotor speed neurocognitive score which will add to the body of knowledge required to manage patients with HIV and AIDS. OBJECTIVE: To determine the relationship between psychomotor speed neurocognitive score and the HIV disease stage in adults at initiation of care. SETTING: This study was conducted at Kangundo Sub-county hospital comprehensive care centre. METHODS: This was a cross-sectional study. All HIV seropositive patients aged 18 to 50 years recently initiated into care were studied. A pretested questionnaire was used to collect data. The World Health Organization (WHO) stage was used during data collection to classify study participants into asymptomatic and symptomatic groups. The grooved pegboard test was used to obtain psychomotor speed neurocognitive scores. Descriptive statistics were used to summarise data. Mann-Whitney U test, Spearman's rho and multiple linear regression were employed in the analysis; p-value of 0.05 was considered significant. RESULTS: The WHO stage did not have a significant effect on the psychomotor speed neurocognitive score (p ≥ 0.05). The CD4 count had a significant effect on psychomotor speed neurocognitive score (p = 0.001). CONCLUSIONS: There was a significant correlation between CD4 counts and psychomotor speed neurocognitive score. Efforts should be made to ensure that the CD4 counts of people living with HIV and AIDS do not continue to fall after initiation into care in order to preserve psychomotor function.
BACKGROUND:Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) is associated with cognitive impairment which affects psychomotor speed. Psychomotor slowing is a predictor of dementia and death in people living with HIV and AIDS. The purpose of this study was to assess the relationship between HIV disease stage and psychomotor speed neurocognitive score which will add to the body of knowledge required to manage patients with HIV and AIDS. OBJECTIVE: To determine the relationship between psychomotor speed neurocognitive score and the HIV disease stage in adults at initiation of care. SETTING: This study was conducted at Kangundo Sub-county hospital comprehensive care centre. METHODS: This was a cross-sectional study. All HIV seropositivepatients aged 18 to 50 years recently initiated into care were studied. A pretested questionnaire was used to collect data. The World Health Organization (WHO) stage was used during data collection to classify study participants into asymptomatic and symptomatic groups. The grooved pegboard test was used to obtain psychomotor speed neurocognitive scores. Descriptive statistics were used to summarise data. Mann-Whitney U test, Spearman's rho and multiple linear regression were employed in the analysis; p-value of 0.05 was considered significant. RESULTS: The WHO stage did not have a significant effect on the psychomotor speed neurocognitive score (p ≥ 0.05). The CD4 count had a significant effect on psychomotor speed neurocognitive score (p = 0.001). CONCLUSIONS: There was a significant correlation between CD4 counts and psychomotor speed neurocognitive score. Efforts should be made to ensure that the CD4 counts of people living with HIV and AIDS do not continue to fall after initiation into care in order to preserve psychomotor function.
Authors: N Sacktor; R L Skolasky; P M Tarwater; J C McArthur; O A Selnes; J Becker; B Cohen; B Visscher; E N Miller Journal: Neurology Date: 2003-08-26 Impact factor: 9.910
Authors: Kevin Robertson; Jeff Liner; James Hakim; Jean-Louis Sankalé; Igor Grant; Scott Letendre; David Clifford; Amadou Gallo Diop; Assan Jaye; Georgette Kanmogne; Alfred Njamnshi; T Dianne Langford; Tufa Gemechu Weyessa; Charles Wood; Mwanza Banda; Mina Hosseinipour; Ned Sacktor; Noeline Nakasuja; Paul Bangirana; Robert Paul; John Joska; Joseph Wong; Michael Boivin; Penny Holding; Betsy Kammerer; Annelies Van Rie; Prudence Ive; Avindra Nath; Kathy Lawler; Clement Adebamowo; Walter Royal; Jeymohan Joseph Journal: J Neurovirol Date: 2010-05 Impact factor: 2.643
Authors: John A Joska; Jennifer Westgarth-Taylor; Landon Myer; Jacqueline Hoare; Kevin G F Thomas; Marc Combrinck; Robert H Paul; Dan J Stein; Alan J Flisher Journal: AIDS Behav Date: 2011-08
Authors: N C Sacktor; H Bacellar; D R Hoover; T E Nance-Sproson; O A Selnes; E N Miller; G J Dal Pan; C Kleeberger; A Brown; A Saah; J C McArthur Journal: J Neurovirol Date: 1996-12 Impact factor: 2.643
Authors: N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira Journal: Neurology Date: 2006-07-25 Impact factor: 9.910
Authors: Quynh T Vo; Christopher Cox; Xiuhong Li; Lisa P Jacobson; Rosemary McKaig; Ned Sacktor; Ola A Selnes; Eileen Martin; James T Becker; Eric N Miller Journal: J Neurovirol Date: 2012-12-11 Impact factor: 2.643
Authors: Georgette D Kanmogne; Julius Y Fonsah; Anya Umlauf; Jacob Moul; Roland F Doh; Anne M Kengne; Bin Tang; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Donald Franklin; Dora M Njamnshi; Callixte T Kuate; Dora Mbanya; Alfred K Njamnshi; Robert K Heaton Journal: Sci Rep Date: 2020-08-20 Impact factor: 4.379